Novo Nordisk bids $9bn for weight problems drug maker Metsera in problem to Pfizer | Prescription drugs trade
Novo Nordisk has launched a shock $9bn (£6.9bn) provide for the US obesity-focused biotech agency Metsera that might gazump an ...
Novo Nordisk has launched a shock $9bn (£6.9bn) provide for the US obesity-focused biotech agency Metsera that might gazump an ...
Copyright © 2025 Greater USA.
Greater USA is not responsible for the content of external sites.